Is seeking how best to approach this rather controversial subject, the uses and abuses of the new synthetic antimalarial remedies, I have decided to record only my own personal experiences with these drugs in the various military stations in India and in China in which I have served.
The first tour of service was spent in the South of India, mostly in Poona an(d Secunderabad. In these two stations, especially the latter, I had ample opportunity of acquainting myself with both the merits and demerits of quinine, so potent and satisfactory in its action on the acute attack, so thoroughly ineffectual in preventing a high relapse rate. In addition, the prolonged treatment then in vogue, the bitter taste, almost impossible to hide, the unpleasant if non-mortal side-effects, and the by no means rare idiosyncrasy evinced by some to its use, even in the smallest doses, were very definite drawbacks.
During my second tour of service abroad I spent a year (March 1928 -March 1929 as Medical Officer in Charge of the Malaria Treatment Centre, Kasauli, where I learned a good deal about plasmoquine and its effects.
The Malaria Treatment Centre was opened here early in 1924 in the hope of finding, from among the multitude of antimalarial drugs already on the market or projected, a really satisfactory treatment for chronic relapsing malaria, at that time by far the most crippling disease with which our Army in India had to cope.
Major, now Lieutenant-Colonel, J. A. Sinton, V.C., O.B.E., was its first commanding officer a very happy choice, as he brought with him a very considerable experience of malaria in all its aspects.
Kasauli was chosen as the site for this new venture for many reasons, not the least important of which was that, at a height of 6,100 ft. above sea-level, it was above the malaria belt in that particular latitude, and the results obtained were therefore not vitiated or distorted by reinfection of susceptible individuals, and one could be sure that any second relapse that occurred at the M.T.C. was due to the inadequacy of the treatment there employed during the first relapse, and not due to reinfection. The routine employed was briefly as follows (S. Smith, 1929) D)uring this convalescent period they performed such fatigues and other duties as were required of them and attended weekly at the out-patient section for certain tests to be made. These comprised blood-film (thick smear) examination, spleen measurement, blood-counts and hwmoglobin estimation, blood-pressure and weight, all of which were recorded on special charts kept for the purpose. Each case, as soon as he relapsed, was immediately transferred to the in-patient section, where he received, under rigi(I test conditions, the antimalarial drug or combination of drugs then under trial or alternativelv the standard control quinine course.
Particulars as to daily parasite count, length of pyrexial period, daily spleen estimation, gain or loss of weight, effect of treatment on the blood-pressure, effect on the blood picture, &c., were again recorded on special charts.
By these means a good deal of specialized information concerning the action of the many drugs and combinations of drugs under trial was accumulated, and has been recorded by Sinton and his collaborators in a series of articles (1926, 1926a, 1927, 1928, 1930) .
Prior to the introduction of plasmoquine, however, none of them compared in anv way with quinine as an antimalarial remedy.
I joined the Malaria Treatment Centre early in 1928, when plasmoquine was under trial. Major Sinton had then taken up the appointment of Director of the Malarial Survey of India, with its headquarters also at Kasauli, but continuied to act in an advisory capacity to the M.T.C. During my year's residence at Kasauli I grew to respect plasmoquine for its marked effect in lowering the relapse rate, but also, in some respects, to dislike it on account of its toxic action in any but the smallest doses. Its action as a gametocide, although of course known, had little local application, as we were not concerned, directly, with reinfections.
My predecessor had given the drug in doses as large as 0 1 grm. daily, and during the early part of my tenure we gave it in appreciably larger doses than is recommended nowadays, viz. 0-06 grm. daily, for twenty-one days, combined with quinine. Under this dosage, a high proportion of patients (over 60%) suffered from toxic manifestations, all of minor degree, which, however, necessitated an interruption of the treatment for several days. Cyanosis due to methoemoglobineemia, and colic referred to the epigastrium were the two toxic symptoms complained of by the great majority of patients. One or both of these symptoms commonly occurred between the sixth and ninth days of treatment if plasmoquine were now withheld for a few days during which the quinine could be persevered with, the toxic manifestations rapidly disappeared, and, in most cases, the full plasmoquine course could then be completed without any return of symptoms.
Later, amongst a small group receiving 0 04 grm. of plasmoquine daily, in combination with quinine, only a small proportion (under 20%o) exhibited toxic manifestations.
Amongst the considerable number of cases treated at the M.T.C. with plasmoquine, there were no examples during my time of severe intolerance to the drug, and all those who exhibited mild toxic symptoms recovered completely after a few days' withdrawal.
One case, however, sent up from the plains, where he had admittedly received a gross overdose of plasmoquine (due to a mistake in the position of the decimal point in prescribing the drug) nearly died soon after arrival. His chief symptoms were marked cyanosis, vomiting, severe epigastric pain, liver tenderness, jaundice, haemoglobinuria. He subsequently had four relapses of malaria, and, as we dare -not give him more plasmoquine, he was eventually invalided home.
This accident led me to emphasize the importance of paying great respect to the correct position of the decimal point in either prescribing or w^riting about these modern synthetic remedies (S. Smith, 1929a daily] given continuously with quinine for twenty-one days, wags the best treatment so far tested for benign tertian malaria, but that " the margin of safety between the therapeutic and toxic doses is so dangerously narrow that daily supervision is necessary in the case of patients undergoing treatment with plasmoquine ". Early in 1932, whilst medical specialist at Rawalpindi, I received from Simla for trial a small supply of a new drug, erion (atebrin), to be given in tablet form combined with plasmoquine, the latter in the usual dose. My first impressions of this combination were bad, several cases exhibiting severe toxic symptoms, and the effect on the malarial attack was far from satisfactory.
It has, of course, been abundantly shown since, that these two drugs, if given in a combined course, should be administered consecutively, not concurrently, as, if given together, the toxic effects of each appear to be enhanced by the presence of the other. given concurrently, atebrin 0 1 grin. three times in the morning, plasmoquine 001 grm.
three times in the evening, for six days; followed by plasmoquine alone for a further five days. I must admit that his results appeared excellent on paper. I did not see the cases under treatment as I only arrived shortly before he left, when malaria was at a low ebb and the relapse-rate was extremely low. The only disadvantage was this question of toxicity.
With my previous experience of the toxic effects of plasmoquine (especially when given concurrently with atebrin) still vivid in my mind, I gave, in the case of benign tertian and quartan infections only, an eight-day course of atebrin alone, reserving for malignant tertian cases a six-day course of atebrin, followed after a rest period of two days, by a five-day course of plasmoquine. This latter course, with one modification presently to be described, worked well, and I had no occasion to alter it.
The atebrin course adopted for benign tertian and quartan cases, whilst proving satisfactory as far as the individual malarial attack was concerned, quite failed to keep down relapses within reasonable limits, and we were faced with a relapse-rate in the region of 3700 reminiscent of the quinine era. I therefore substituted the combined atebrin-plasmoquine course for all forms of malaria, which, previously, I had reserved for malignant tertian cases only. The result was an immediate drop in the relapse rate to under 6%.
From the middle of 1937 I have adopted this combined (or consecutive) atebrinplasmoquine course for all forms of malaria, introducing latterly two important modifications.
Although at first quite satisfied with atebrin in so far as its action on the acute attack was concerned, latterly I have come to the conclusion, as indeed have others (Amy and Boyd, 1936b) , that its action on the initial fever is notably slower than that of quinine.
To test this point, I treated a series of cases of benign tertian malaria with an initial two-days' course of quinine, switching over to the atebrin course at the end of this period. The effect of this change on the initial pyrexia was at once evident; the duration of fever being reduced on an average by nearly one day as a direct result.
(Duration of fever after commencing with atebrin averaged 1-5 days; duration of fever after commencing with quinine averaged 0-6 day.)
During the summer months we had amongst our admissions for malignant tertian malaria a considerable proportion of serious cases, some few of which were of the grave cerebral type.
To add to our difficulties, several, who on first admission appeared to give no special grounds for anxiety, on the third or fourth day after admission became-gravely ill, either collapsing with a subnormal temperature or, in one case, dying after a short bout of hyperpyrexia.
Post-mortem examination in two such cases revealed no large aggregation of malignant tertian parasites in the internal organs. In one case (collapse) the suprarenal bodies were found to contain small cortical heemorrhages and areas of necrosis.
An excellent description of anomalous cases of this type with very similar postmortem findings is to be found in the Official History of the War, Medical Services (1922) .
With these unfortunate occurrences in our mind, and being impressed by the fact that there was nothing in their condition on admission to suggest they would develop these alarming symptoms, we have given latterly all cases admitted with malignant tertian malaria one to three intramuscular injections of atebrin musonate as a preliminary, at daily intervals, completing the six-day course with oral atebrin. A similar routine was carried out at the Royal Naval Hospital, Hong Kong.
We have, so far, treated some 50 cases of malignant tertian malaria with these initial intramuscular ii4ections of atebrin musonate and have every reason to be satisfied, and I am convin6ed it is a life-'saving iheasure. We lVid. no bad results, local -or general, attributable to atebrin, either given intramuscularly o*r orally.
On the whole, I prefer intramuscular atebrin to either intramuscular or intravenous quinine in the treatment of these malarial emergencies. Atebrin musonate may also be given as an intravenous injection but this route is not recommended by the manufacturers who maintain, probably correctly, that the absorption of this drug is almost as rapid by intramuscular as by intravenous injection, and less dangerous by the former route.
There was one disastrous period, luckily short, during 1938, when I departed from my practice of never giving atebrin and plasmoquine in actual combination, and gave, for a limited period, pellets of combined atebrin and plasmoquine (atebrin 01 grmi.; plasmoquine 0 005 grm.) under the mistaken impression that plasmoquine, in this minute dosage, even when combined with atebrin, would have no ill-effect. Apparently I was wrong in this supposition, for whilst the majority of the cases thus treated gave no cause for anxiety and ran a normal course, one case of malignant tertian malaria died suddenly on the fifth day after admission; a second died eight days after admission; and yet a third developed severe agranulocytosis and only recovered after a stormy course.
The proportion of unfortunate occurrences in this small series of 12 cases appeared much too high to be entirely coincidental, so we stopped this combination treatment.
When to apply the therapeutic test of quinine or atebrin in undiagnosed but suspected malaria has always presented a difficult problem.
Formerly, I believed that, provided the patient remained in hospital under constant medical supervision, two blood slides (preferably thick films) at least being taken daily and examined at once by a competent observer, until a positive diagnosis is arrived at, one could, with some degree of safety, delay the exhibition of the specific antimalarial remedy until a positive blood slide was obtained. I have in the past delayed the commencement of specific treatment up to ten to twelve days in such cases.
Whilst admitting that this doctrine may still hold good where only benign tertian or quartan infections are met with, it is dangerous in districts like Hong Kong where severe malignant tertian infections are to be expected.
The danger of thus temporizing was shown by one unfortunate case A bombardier was admitted to hospital from a very malarious district during the summer, complaining of malaise, slight irregular fever, and headache, which he said, he had had off and on for a month. His wife had been a hospital nurse, and although she denied having given him any drug other than aspirin, I suspect he must have had quinine prior to admission. For five days after admission he ran a high remittent fever with occasional rigors. The spleen was not palpable; the temperature not of the alternating type, and blood-films, taken twice or thrice daily, were consistently negative. On the sixth day after admission a blood-film showed, for the first time, an exceedingly heavy infection with malignant tertian rings. His clinical condition at this time gave no special cause for anxiety and he was put on the standard atebrin course forthwith. In spite of energetic antimalarial treatment, however, he died three days later.
Autopsy revealed a moderate (legree of malarial pigment in the spleen and brain capillaries but no large aggregation of parasites in any of the internal organ>.
Later, another complicating factor arose, in that most of our cases had received, prior to admission, prophylactic quinine-that bugbear of the clinician and clinical pathologist and positive blood slides became the exception rather than the rule.
In my annual medical report for 1938 I noted that "Difficulty was experienced during the latter three months of the year in obtaining positive blood slides owing to the fact that the Artillery at Lymun and the Battalion at San Wai Camp, in the New Territories, were on prophylactic quinine prior to their admission to hospital. On this account there was from these two units, especially the latter, a high proportion of cases diagnosed as 'clinical malaria', who, on clinical grounds, were almost certainly suffering from malaria, but in whom blood slides examined twice daily, were consistently negative.
" An ave'rage of three days elapsed before positive blood slides were obtained in the case of those who had been on prophylactic quinine prior to admission; whereas in the ease of those who had not been on prophylactic quinine positive slides were obtained on an average in 1-5 days. Also, the incidence of clinical malaria was much heavier amongst those who had been on prophylactic quinine."
Of a total of 228 admissions for malaria during 1938, when prophylactic quinine was in vogue, 32 were classified as clinical malaria, the great majority coming from amongst the two units which were on prophylactic quinine, whereas amongst a total admission rate of 211 during 1937, when some units were on prophylactic atebrin, but none on quinine, there was only one diagnosed clinical malaria, and he had not been on any form of prophylactic treatment prior to admission.
One must admit that the results obtained with either form of prophylactic treatinent were far from conclusive.
It is for cases such as the above that one might hope to obtain some help from such In these circumstances we decided, somewhat reluctantlv, to give all cases admitted during the malaria season, and exhibiting fever which did not respond rapidly to symptomatic treatment, some form of antimalarial therapy, preferably atebrin. We preferred atebrin to quinine because it appears to have a provocative action not possessed by quinine, and parasites are often found in the peripheral blood for the first time after a few doses of atebrin.
Tebetren. This antimalarial remedy was sent us by the War Office for trial as an alternative to atebrin and plasmoquine, both of which might, in certain eventualities, become non-available. The drug is said to be cumulative in its action, and both these authors report a proportion of toxic side effects in their cases, Barrowman stating that the " margin between the therapeutic and noxious doses is small ".
We were only sent a limited supply, insufficient for extended trials, and we were unable to supplement our stock from local supplies, the drug being unprocurable in Hong Kong.
We used it almost exclusively in benign tertian infections, and its action on the acute attack was almost identical with that of atebrin. The relapse-rate following its use was also somewhat high, about 36% amongst cases treated with the drug during 1937, again about the same as with atebrin. We had a lower relapse rate of approximately 17-6% with a second batch of cases treated during 1938 (this does not take into account, however, the spring relapses, which will undoubtedly materially raise this figure).
In the small dosage we emnployed 6 gr. three times daily for eight days-wNe hadt no ill-effects.
I have no personal experience of the new antimalarial remedy, certuna, which, according to its discoverer Kikuth, is superior in its action to plasmoquine, in that it is gametocidal without producing the toxic manifestations of the latter.
Of the synthetic remedies I have mentioned, therefore, we have in atebrin a drug which has an excellent and rapid effect on the acute attack, especially if reinforced by quinine, rapidly frees the peripheral blood of parasites, is almost non-toxic, and is not unpleasant to take. On the other hand, it is little, if any, better than quinine in reducing the relapse-rate in benign tertian malaria, and it has little or no action on the gametocyte (crescent) stage of malignant tertian malaria.
Plasmoquine, on the other hand, has a relatively poor effect on the acute (trophozoite) stage of the disease, and is seldom used alone, for this reason: it is very toxic in all but the smallest doses, and many have an idiosyncrasy even to such small doses ; it is, however, almost indispensable as an adjuvant to other treatments, chiefly because of its marked effect in reducing the relapse-rate, and also because of its rapid action on the sexual, crescent forms of malignant tertian malaria, which sterilizes the patient as far as his carrier state is concerned.
Tebetren, as far as our limited experience goes, would appear to have much the same clinical effects and limitations as atebrin.
